752 related articles for article (PubMed ID: 31109339)
21. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
Harris RE; Richardson J; Frasso R; Anderson ED
Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
[TBL] [Abstract][Full Text] [Related]
22. A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts.
Hassan R; Roland KB; Hernandez B; Goldman L; Evans KN; Gaul Z; Agnew-Brune C; Buchacz K; Fukuda HD
J Subst Abuse Treat; 2022 Jul; 138():108722. PubMed ID: 35067399
[TBL] [Abstract][Full Text] [Related]
23. "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City.
Muncan B; Walters SM; Ezell J; Ompad DC
Harm Reduct J; 2020 Jul; 17(1):53. PubMed ID: 32736624
[TBL] [Abstract][Full Text] [Related]
24. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
Carnes NA; Asher AK; Bohm MK; Bessler PA
Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
[TBL] [Abstract][Full Text] [Related]
25. Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.
O'Rourke A; White RH; Park JN; Rodriguez K; Kilkenny ME; Sherman SG; Allen ST
Harm Reduct J; 2019 Aug; 16(1):51. PubMed ID: 31470864
[TBL] [Abstract][Full Text] [Related]
26. A qualitative exploration of barriers and facilitators to drug treatment services among people who inject drugs in west Virginia.
Winiker AK; Schneider KE; Hamilton White R; O'Rourke A; Grieb SM; Allen ST
Harm Reduct J; 2023 Jun; 20(1):69. PubMed ID: 37264367
[TBL] [Abstract][Full Text] [Related]
27. Injection risk norms and practices among migrant Puerto Rican people who inject drugs in New York City: The limits of acculturation theory.
Gelpí-Acosta C; Guarino H; Benoit E; Deren S; Pouget ER; Rodríguez A
Int J Drug Policy; 2019 Jul; 69():60-69. PubMed ID: 31196730
[TBL] [Abstract][Full Text] [Related]
28. Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17 U.S. cities, 2015.
Whiteman A; Burnett J; Handanagic S; Wejnert C; Broz D;
Int J Drug Policy; 2020 Nov; 85():102923. PubMed ID: 32920424
[TBL] [Abstract][Full Text] [Related]
29. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky.
Glick JL; Grieb SM; Harris SJ; Weir BW; Smith KC; Puryear T; Hamilton White R; Allen ST
Harm Reduct J; 2022 May; 19(1):47. PubMed ID: 35590373
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Syringe Services Program Policy on Risk Behaviors Among Persons Who Inject Drugs in 3 US Cities, 2005-2015.
Nassau T; Al-Tayyib A; Robinson WT; Shinefeld J; Brady KA
Public Health Rep; 2020; 135(1_suppl):138S-148S. PubMed ID: 32735193
[TBL] [Abstract][Full Text] [Related]
31. Differential access to syringe exchange and other prevention activities among people who inject drugs in rural and urban areas of Puerto Rico.
Welch-Lazoritz M; Habecker P; Dombrowski K; Rivera Villegas A; Davila CA; Rolón Colón Y; Miranda De León S
Int J Drug Policy; 2017 May; 43():16-22. PubMed ID: 28160735
[TBL] [Abstract][Full Text] [Related]
32. Hospital admissions among people who inject opioids following syringe services program implementation.
Bornstein KJ; Coye AE; St Onge JE; Li H; Muller A; Bartholomew TS; Tookes HE
Harm Reduct J; 2020 May; 17(1):30. PubMed ID: 32398059
[TBL] [Abstract][Full Text] [Related]
33. Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington.
Glick SN; Burt R; Kummer K; Tinsley J; Banta-Green CJ; Golden MR
Drug Alcohol Depend; 2018 Jan; 182():86-92. PubMed ID: 29175463
[TBL] [Abstract][Full Text] [Related]
34. Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.
Bartholomew TS; Tookes HE; Spencer EC; Feaster DJ
Ann Med; 2022 Dec; 54(1):2137-2150. PubMed ID: 35900201
[TBL] [Abstract][Full Text] [Related]
35. Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study.
Chayama KL; Ng C; Fleming T; Small W; Sue KL; McNeil R
Harm Reduct J; 2023 Sep; 20(1):126. PubMed ID: 37679789
[TBL] [Abstract][Full Text] [Related]
36. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
[TBL] [Abstract][Full Text] [Related]
37. Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak.
Patel MR; Foote C; Duwve J; Chapman E; Combs B; Fry A; Hall P; Roseberry J; Brooks JT; Broz D
J Acquir Immune Defic Syndr; 2018 Apr; 77(4):373-382. PubMed ID: 29271829
[TBL] [Abstract][Full Text] [Related]
38. Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone.
Schneider KE; O'Rourke A; White RH; Park JN; Musci RJ; Kilkenny ME; Sherman SG; Allen ST
Int J Drug Policy; 2020 Feb; 76():102642. PubMed ID: 31918401
[TBL] [Abstract][Full Text] [Related]
39. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
[TBL] [Abstract][Full Text] [Related]
40. Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation.
Corneli A; Perry B; Des Marais A; Choi Y; Chen H; Lilly R; Ayers D; Bennett J; Kestner L; Meade CS; Sachdeva N; McKellar MS
Harm Reduct J; 2022 Dec; 19(1):132. PubMed ID: 36463214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
